178 related articles for article (PubMed ID: 17237685)
21. Control of bleeding in endoscopic sinus surgery: use of a novel gelatin-based hemostatic agent.
Gall RM; Witterick IJ; Shargill NS; Hawke M
J Otolaryngol; 2002 Oct; 31(5):271-4. PubMed ID: 12512890
[TBL] [Abstract][Full Text] [Related]
22. External versus endoscopic dacryocystorhinostomy for acquired nasolacrimal duct obstruction in a tertiary referral center.
Ben Simon GJ; Joseph J; Lee S; Schwarcz RM; McCann JD; Goldberg RA
Ophthalmology; 2005 Aug; 112(8):1463-8. PubMed ID: 15953636
[TBL] [Abstract][Full Text] [Related]
23. Improvement of hemostasis in open and laparoscopically performed partial nephrectomy using a gelatin matrix-thrombin tissue sealant (FloSeal).
Richter F; Schnorr D; Deger S; Trk I; Roigas J; Wille A; Loening SA
Urology; 2003 Jan; 61(1):73-7. PubMed ID: 12559270
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of hemostatic gelatin sponge as a packing material after septoplasty: A prospective, randomized, multicenter study.
Kim SD; Hong SL; Kim MJ; Kim JY; Kim YW; Koo SK; Cho KS
Auris Nasus Larynx; 2018 Apr; 45(2):286-290. PubMed ID: 28552274
[TBL] [Abstract][Full Text] [Related]
25. Use of Floseal®, a human gelatine-thrombin matrix sealant, in surgery: a systematic review.
Echave M; Oyagüez I; Casado MA
BMC Surg; 2014 Dec; 14():111. PubMed ID: 25528250
[TBL] [Abstract][Full Text] [Related]
26. Damage control management of experimental grade 5 renal injuries: further evaluation of FloSeal gelatin matrix.
Pursifull NF; Morris MS; Harris RA; Morey AF
J Trauma; 2006 Feb; 60(2):346-50. PubMed ID: 16508494
[TBL] [Abstract][Full Text] [Related]
27. Use of FloSeal hemostatic sealant in transsphenoidal pituitary surgery: technical note.
Ellegala DB; Maartens NF; Laws ER
Neurosurgery; 2002 Aug; 51(2):513-5; discussion 515-6. PubMed ID: 12182794
[TBL] [Abstract][Full Text] [Related]
28. Gelatin matrix use reduces postoperative bleeding after total knee arthroplasty.
Velyvis JH
Orthopedics; 2015 Feb; 38(2):e118-23. PubMed ID: 25665116
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of external dacryocystorhinostomy and endoscopic endonasal dacryocystorhinostomy in the management of nasolacrimal duct obstruction.
Duwal S; Saiju R
Nepal J Ophthalmol; 2015; 7(1):39-46. PubMed ID: 26695604
[TBL] [Abstract][Full Text] [Related]
30. FloSeal hemostatic matrix in persistent epistaxis: prospective clinical trial.
Côté D; Barber B; Diamond C; Wright E
J Otolaryngol Head Neck Surg; 2010 Jun; 39(3):304-8. PubMed ID: 20470677
[TBL] [Abstract][Full Text] [Related]
31. The Safety and Efficacy of Adjuvant Hemostatic Agents During Laparoscopic Nephron-Sparing Surgery: Comparison of Tachosil and Floseal Versus No Hemostatic Agents.
Tonyali S; Koni A; Yazici S; Bilen CY
Urol J; 2017 Jan; 15(1):21-25. PubMed ID: 29277887
[TBL] [Abstract][Full Text] [Related]
32. [Improvement of hemostasis in laparoscopic and open partial nephrectomy with gelatin thrombin matrix (FloSeal)].
Richter F; Tüllmann ME; Türk I; Deger S; Roigas J; Wille A; Schnorr D
Urologe A; 2003 Mar; 42(3):338-46. PubMed ID: 12671767
[TBL] [Abstract][Full Text] [Related]
33. Hemostatic matrix sealant in neurosurgery: a clinical and imaging study.
Gazzeri R; Galarza M; Neroni M; Alfieri A; Giordano M
Acta Neurochir (Wien); 2011 Jan; 153(1):148-54; discussion 155. PubMed ID: 20703888
[TBL] [Abstract][Full Text] [Related]
34. Floseal only versus in combination in spine surgery: a comparative, retrospective hospital database evaluation of clinical and healthcare resource outcomes.
Ramirez MG; Deutsch H; Khanna N; Cheatem D; Yang D; Kuntze E
Hosp Pract (1995); 2018 Oct; 46(4):189-196. PubMed ID: 29986148
[TBL] [Abstract][Full Text] [Related]
35. Reducing blood loss at myomectomy with use of a gelatin-thrombin matrix hemostatic sealant.
Raga F; Sanz-Cortes M; Bonilla F; Casañ EM; Bonilla-Musoles F
Fertil Steril; 2009 Jul; 92(1):356-60. PubMed ID: 19423098
[TBL] [Abstract][Full Text] [Related]
36. The effectiveness of FloSeal matrix hemostatic agent in thyroid surgery: a prospective, randomized, control study.
Testini M; Marzaioli R; Lissidini G; Lippolis A; Logoluso F; Gurrado A; Lardo D; Poli E; Piccinni G
Langenbecks Arch Surg; 2009 Sep; 394(5):837-42. PubMed ID: 19421770
[TBL] [Abstract][Full Text] [Related]
37. Clinical usefulness of endoscopic intranasal dacryocystorhinostomy.
Ishio K; Sugasawa M; Tayama N; Kaga K
Acta Otolaryngol Suppl; 2007 Dec; (559):95-102. PubMed ID: 18340578
[TBL] [Abstract][Full Text] [Related]
38. Hemostatic gelatine-thrombin matrix (Floseal®) facilitates hemostasis and organ preservation in laparoscopic treatment of tubal pregnancy.
Watrowski R
Arch Gynecol Obstet; 2014 Sep; 290(3):411-5. PubMed ID: 24816598
[TBL] [Abstract][Full Text] [Related]
39. Minimal craniotomy and matrix hemostatic sealant for the treatment of spontaneous supratentorial intracerebral hemorrhage.
Gazzeri R; Galarza M; Neroni M; Alfieri A; Esposito S
J Neurosurg; 2009 May; 110(5):939-42. PubMed ID: 19061356
[TBL] [Abstract][Full Text] [Related]
40. FloSeal: a new hemostyptic agent in peripheral vascular surgery.
Reuthebuch O; Lachat ML; Vogt P; Schurr U; Turina M
Vasa; 2000 Aug; 29(3):204-6. PubMed ID: 11037719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
